We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ADVM market cap is 57.03M. The company's latest EPS is USD -6.2672 and P/E is -0.44.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 1M | 0 | 0 |
| Operating Income | -26.84M | -20.88M | -29.22M | -62.22M | -48.22M |
| Net Income | -24.79M | -18.48M | -27.13M | -60.53M | -47.02M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 7.5M | 0 | 3.6M | 1M |
| Operating Income | -117.95M | -146.12M | -157.14M | -123.99M | -139.16M |
| Net Income | -117.51M | -145.54M | -154.54M | -117.17M | -130.93M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 267.83M | 253.8M | 234.38M | 179.84M | 137.65M |
| Total Liabilities | 85.54M | 85.77M | 90.26M | 109.13M | 111.23M |
| Total Equity | 182.29M | 168.03M | 144.12M | 70.71M | 26.42M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 482.57M | 439.73M | 308.37M | 173.01M | 179.84M |
| Total Liabilities | 48.22M | 123.54M | 126.85M | 89.54M | 109.13M |
| Total Equity | 434.35M | 316.19M | 181.52M | 83.47M | 70.71M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -23.25M | -43.09M | -64.21M | -92.46M | -42.77M |
| Investing | -22.03M | -24.35M | -37.7M | -41.89M | 31.28M |
| Financing | 119.88M | 119.76M | 119.76M | 120M | N/A |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -79.29M | -107.83M | -108.09M | -90.9M | -92.46M |
| Investing | -280.17M | 78.71M | 141.72M | 96.88M | -41.89M |
| Financing | 355.99M | 2.4M | 607k | 69k | 120M |
| Market Cap | 57.03M |
| Price to Earnings Ratio | -0.44 |
| Price to Sales Ratio | 56.99 |
| Price to Cash Ratio | 0.94 |
| Price to Book Ratio | 0.81 |
| Dividend Yield | - |
| Shares Outstanding | 20.89M |
| Average Volume (1 week) | 138.97k |
| Average Volume (1 Month) | 331.8k |
| 52 Week Change | -65.83% |
| 52 Week High | 10.14 |
| 52 Week Low | 1.78 |
| Spread (Intraday) | 0.02 (0.73%) |
| Company Name | Adverum Biotechnologies Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.adverum.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
